Skip to main content
Marinomed Biotech AG logo

Marinomed Biotech AG — Investor Relations & Filings

Ticker · MARI ISIN · ATMARINOMED6 LEI · 529900GN3B1EN80XF405 VI Manufacturing
Open in API
Filings indexed 427 across all filing types
Latest filing 2026-03-31 Director's Dealing
Country AT Austria
Listing VI MARI

About Marinomed Biotech AG

https://www.marinomed.com/en

Marinomed Biotech AG is a biopharmaceutical company that develops medicinal products and medical devices for viral infectious diseases and immunological disorders. The company's innovation is driven by proprietary, patent-protected technology platforms. The Marinosolv platform enhances the solubility and bioavailability of poorly soluble compounds, enabling the development of treatments for immunological conditions such as allergies, asthma, and inflammatory diseases. The virology platform is the basis for therapies targeting viral respiratory infections. Marinomed maintains a development pipeline, has globally marketed therapeutics, and offers its technology through partnerships and services via its Solv4U unit.

Recent filings

Filing Released Lang Actions
EQS-DD: Marinomed Biotech AG: Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
Director's Dealing Classification · 1% confidence The document is a notification under Art 19 MAR detailing share transactions by a director (Karl Mahler) of Marinomed Biotech AG, including instrument description, transaction type, volume, price, date, and venue. This matches the definition of "Director's Dealing" disclosures.
2026-03-31 German
EQS-DD: Marinomed Biotech AG: Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
Director's Dealing Classification · 1% confidence The document is a notification and public disclosure of transactions by persons discharging managerial responsibilities (insider trades under Article 19 MAR). It details the names of the insiders, instrument descriptions, volumes, prices, transaction dates, and venues. This clearly fits the Directors’ Dealing category.
2026-03-31 German
EQS-DD: Marinomed Biotech AG: Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
Director's Dealing Classification · 1% confidence The document is a notification under Art.19 MAR detailing personal share transactions by a company insider (Simon Nebel). This matches the “Director’s Dealing” category, which covers insider trades by directors or related persons. Therefore it is classified as DIRS.
2026-03-31 German
Marinomed Biotech AG: Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
Director's Dealing Classification · 1% confidence The document is a public disclosure under Article 19 MAR (“Directors’ Dealings”), detailing transactions by a person discharging managerial responsibilities and closely associated persons, including instrument description, volume, price, date, and venue. This matches the insider share transaction reporting requirements for directors. Therefore, it is classified as a Director’s Dealing (DIRS).
2026-03-31 German
EQS-DD: Marinomed Biotech AG: Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
Director's Dealing Classification · 1% confidence The document is a regulatory announcement of transactions by persons discharging managerial responsibilities (an insider dealing disclosure under MAR Art. 19). It lists details of the director’s acquisition of subscription rights, instrument identifiers, volumes, prices, dates, and places. This matches the ‘Director’s Dealing’ category.
2026-03-31 German
EQS-DD: Marinomed Biotech AG: Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
Director's Dealing Classification · 1% confidence The document is a notification under Art 19 MAR concerning transactions in the company’s own securities by a person discharging managerial responsibilities (Eva Prieschl-Grassauer). It contains detailed insider transaction data (type of instrument, volume, price, date, place). This matches the “Director’s Dealing” category (Code: DIRS).
2026-03-31 German

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.